2
Total investments
2
Early stage
0
Mid stage
0
Late stage
10y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Senior Advisor / Investor
Mar 2017
Leucadia Therapeutics is a preclinical stage biotech company, developing a novel approach to treating Alzheimer's disease. We also have 8 Apps to exercise your brain, including a personal memory tracker. See procogny.com for links to App Store and Google Play.
Advisor / Investor
Dec 2016
Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases.
When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function.
Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases.
Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.
Experience · 5 entries
All (5)
Investments (2)
Founder (2)
2020
Co-Founder
Sep 2020
ELEVATING LIVES THROUGH CUTTING-EDGE CARE.
At Everest Health, we are dedicated to pushing the boundaries of medical science to help people live longer, happier, and healthier lives. Our purpose drives us to deliver the most advanced healthcare solutions, always keeping the patient at the center of everything we do. With a vision to be the best healthcare provider in the world, we aim to revolutionize the medical field by offering millionaire-level care that is accessible and affordable for everyone.
OUR MISSION IS CLEAR: to integrate the latest breakthroughs in medicine into our patient care, ensuring that everyone benefits from the forefront of scientific advancement. We are committed to maintaining our reputation for scientific rigor and leadership, continually setting the standard for quality in healthcare.
At Everest Health, our values guide every decision we make. We prioritize
ADVANCEMENT through relentless research and development, ensuring that our treatments are always at the cutting edge. QUALITY is non-negotiable; we
strive to provide the highest standard of care to all, regardless of financial status. Our REPUTATION is built on a foundation of excellence and innovation, and we take pride in our role as leaders in the medical field. EMPATHY is at the heart of our approach, as we believe that true care means making every patient feel heard, seen, and genuinely cared for. Finally, COLLABORATION with patients and scientists alike is essential to our practice, fostering shared decision-making and ensuring that every treatment plan is tailored to the unique needs of the individual.
At Everest Health, we are more than just a healthcare provider—we are a partner in your journey to a longer, healthier, and happier life.
2018
CoFounder & Chief Operating Officer
Sep 2018
Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.
In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.
Join us as we embark on the task to "turn back time."
2017
Senior Advisor / Investor
Mar 2017
Leucadia Therapeutics is a preclinical stage biotech company, developing a novel approach to treating Alzheimer's disease. We also have 8 Apps to exercise your brain, including a personal memory tracker. See procogny.com for links to App Store and Google Play.
2016
Advisor / Investor
Dec 2016
Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases.
When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function.
Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases.
Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.
2002
